These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32468469)

  • 61. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Engineering extracellular vesicles for Alzheimer's disease: An emerging cell-free approach for earlier diagnosis and treatment.
    Lazar SV; Mor S; Wang D; Goldbloom-Helzner L; Clark K; Hao D; Farmer DL; Wang A
    WIREs Mech Dis; 2022 Mar; 14(2):e1541. PubMed ID: 35266650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Traumatic Brain Injury.
    Karnati HK; Garcia JH; Tweedie D; Becker RE; Kapogiannis D; Greig NH
    J Neurotrauma; 2019 Apr; 36(7):975-987. PubMed ID: 30039737
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer's Disease before Symptom Onset.
    Palade J; Alsop E; Courtright-Lim A; Hsieh M; Whitsett TG; Galasko D; Van Keuren-Jensen K
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334599
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges.
    Hornung S; Dutta S; Bitan G
    Front Mol Neurosci; 2020; 13():38. PubMed ID: 32265650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The emerging role of exosomes in Alzheimer's disease.
    Zhang T; Ma S; Lv J; Wang X; Afewerky HK; Li H; Lu Y
    Ageing Res Rev; 2021 Jul; 68():101321. PubMed ID: 33727157
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biomarkers in Alzheimer's disease drug development.
    Cummings JL
    Alzheimers Dement; 2011 May; 7(3):e13-44. PubMed ID: 21550318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PAHs increase the production of extracellular vesicles both in vitro in endothelial cells and in vivo in urines from rats.
    Le Goff M; Lagadic-Gossmann D; Latour R; Podechard N; Grova N; Gauffre F; Chevance S; Burel A; Appenzeller BMR; Ulmann L; Sergent O; Le Ferrec E
    Environ Pollut; 2019 Dec; 255(Pt 1):113171. PubMed ID: 31539851
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
    Xu R; Greening DW; Rai A; Ji H; Simpson RJ
    Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 72. (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.
    Becker RE; Greig NH; Lahiri DK; Bledsoe J; Majercik S; Ballard C; Aarsland D; Schneider LS; Flanagan D; Govindarajan R; Sano M; Ferrucci L; Kapogiannis D
    Curr Alzheimer Res; 2018; 15(9):883-891. PubMed ID: 29318971
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Proteomics Approach to Identify Biomarkers in Neurodegenerative Diseases.
    Nayak A; Salt G; Verma SK; Kishore U
    Int Rev Neurobiol; 2015; 121():59-86. PubMed ID: 26315762
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model.
    Capsoni S; Brandi R; Arisi I; D'Onofrio M; Cattaneo A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):635-47. PubMed ID: 21631402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration.
    Pérez M; Hernández F; Avila J
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942527
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The multiple roles of exosomes in Parkinson's disease: an overview.
    Porro C; Panaro MA; Lofrumento DD; Hasalla E; Trotta T
    Immunopharmacol Immunotoxicol; 2019 Aug; 41(4):469-476. PubMed ID: 31405314
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.
    Perneczky R; Kempermann G; Korczyn AD; Matthews FE; Ikram MA; Scarmeas N; Chetelat G; Stern Y; Ewers M
    BMC Med; 2019 Feb; 17(1):47. PubMed ID: 30808345
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ratio Aβ1-42:p-Tau: a Possible Diagnostic Tool in Differentiating Dementias.
    De Riva V; Galloni E; Lealini B; Zarantonello G; Disco C; Dionisio LD; Meligrana L; Marcon M; Perini F
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115229
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exosomes in Alzheimer's disease.
    Malm T; Loppi S; Kanninen KM
    Neurochem Int; 2016 Jul; 97():193-9. PubMed ID: 27131734
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
    Cedazo-Minguez A; Winblad B
    Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.